DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Radium ra-223 dichlorideis the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
Radium ra-223 dichloride has thirty-four patent family members in twenty-one countries.
One supplier is listed for this compound.
Recent Clinical Trials for radium ra-223 dichloride
Identify potential brand extensions & 505(b)(2) entrants
|City of Hope Medical Center||Phase 2|
|National Cancer Institute (NCI)||Phase 1/Phase 2|
|National Cancer Institute (NCI)||Phase 2|
Pharmacology for radium ra-223 dichloride
|Drug Class||Radioactive alpha-Particle Emitting Therapeutic Agent |
|Mechanism of Action||alpha-Particle Emitting Activity |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Bayer Hlthcare||XOFIGO||radium ra-223 dichloride||SOLUTION;INTRAVENOUS||203971-001||May 15, 2013||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|1140212||C300666||Netherlands||Start Trial||PRODUCT NAME: RADIUM-223, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/13/873/001 20131113|
|1140212||CR 2014 00027||Denmark||Start Trial||PRODUCT NAME: RADIUM-223 OG OPLOESELIGE SALTE DERAF, HERUNDER RADIUM-223 DICHLORID; REG. NO/DATE: EU/1/13/873 20131113|
|1140212||92425||Luxembourg||Start Trial||PRODUCT NAME: DICHLORURE DE RADOIM RA 2232 ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES(XOFIGO)|
|1140212||122014000052||Germany||Start Trial||PRODUCT NAME: RADIUM-223-SALZ, INSBESONDERE RADIUM-223-DICHLORID; REGISTRATION NO/DATE: EU/1/13/873 20131113|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.